Pollution level, phase distribution and source analysis of polycyclic aromatic hydrocarbons in residential air in Hangzhou, ChinaLIZHONG ZHU; HAO LU; SHUGUANG CHEN et al.Journal of hazardous materials (Print). 2009, Vol 162, Num 2-3, pp 1165-1170, issn 0304-3894, 6 p.Article

Phase-controlled solvothermal synthesis and characterization of nickel sulfides with good single crystalline natureSHUGUANG CHEN; KAI ZENG; HAIBIN LI et al.Journal of solid state chemistry (Print). 2011, Vol 184, Num 8, pp 1989-1996, issn 0022-4596, 8 p.Article

Levels, sources, and health risks of carbonyls in residential indoor air in Hangzhou, ChinaMILI WENG; LIZHONG ZHU; KUN YANG et al.Environmental monitoring and assessment. 2010, Vol 163, Num 1-4, pp 573-581, issn 0167-6369, 9 p.Article

Surface self-diffusion of adatom on Pt cluster with truncated octahedron structureJIANYU YANG; WANGYU HU; SHUGUANG CHEN et al.Thin solid films. 2010, Vol 518, Num 14, pp 4041-4045, issn 0040-6090, 5 p.Article

Levels and health risks of carbonyl compounds in selected public places in Hangzhou, ChinaMILI WENG; LIZHONG ZHU; KUN YANG et al.Journal of hazardous materials (Print). 2009, Vol 164, Num 2-3, pp 700-706, issn 0304-3894, 7 p.Article

Novel Fe doped mesoporous TiO₂ microspheres: Ultrasonic-hydrothermal synthesis, characterization, and photocatalytic propertiesHAIBIN LI; GUOCONG LIU; SHUGUANG CHEN et al.Physica. E, low-dimentional systems and nanostructures. 2010, Vol 42, Num 6, pp 1844-1849, issn 1386-9477, 6 p.Article

Synthesis and characterization of monoclinic BiVO₄ nanorods and nanoplates via microemulsion-mediated hydrothermal methodHAIBIN LI; GUOCONG LIU; SHUGUANG CHEN et al.Physica. E, low-dimentional systems and nanostructures. 2011, Vol 43, Num 7, pp 1323-1328, issn 1386-9477, 6 p.Article

The effect of agitation on volatilization of naphthalene from solution containing surfactantCHAOYING YAO; SUJUN JIN; XUEYOU SHEN et al.Journal of hazardous materials (Print). 2009, Vol 164, Num 1, pp 195-203, issn 0304-3894, 9 p.Article

Effect of Prednisone on the Pharmacokinetics of the Integrase Inhibitor DolutegravirSONG, Ivy H; BORLAND, Julie; SHUGUANG CHEN et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 9, pp 4394-4397, issn 0066-4804, 4 p.Article

Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitorsSHUGUANG CHEN; RAN CHEN; MEIZI HE et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 5, pp 1948-1956, issn 0968-0896, 9 p.Article

Pharmacokinetic Properties of Single-Dose Lamivudine/Adefovir Dipivoxil Fixed-Dose Combination in Healthy Chinese Male VolunteersFOK, Benny S. P; GARDNER, Stephen; PISCITELLI, Steve et al.Clinical therapeutics. 2013, Vol 35, Num 1, pp 68-76, issn 0149-2918, 9 p.Article

Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744FORD, Susan L; GOULD, Elizabeth; SHUGUANG CHEN et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 11, pp 5472-5477, issn 0066-4804, 6 p.Article

Effect of Food on the Pharmacokinetics of the Integrase Inhibitor DolutegravirSONG, Ivy; BORLAND, Julie; SHUGUANG CHEN et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 3, pp 1627-1629, issn 0066-4804, 3 p.Article

Effect of a Single Supratherapeutic Dose of Dolutegravir on Cardiac RepolarizationSHUGUANG CHEN; MIN, Sherene S; PEPPERCORN, Amanda et al.Pharmacotherapy. 2012, Vol 32, Num 4, pp 333-339, issn 0277-0008, 7 p.Article

Relative bioavailability of a paediatric granule formulation of the HIV integrase inhibitor dolutegravir in healthy adult subjectsPATEL, Parul; SONG, Ivy; BORLAND, Julie et al.Antiviral therapy (London). 2014, Vol 19, Num 3, pp 229-233, issn 1359-6535, 5 p.Article

Effects of Etravirine Alone and with Ritonavir-Boosted Protease Inhibitors on the Pharmacokinetics of DolutegravirSONG, Ivy; BORLAND, Julie; MIN, Sherene et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 7, pp 3517-3521, issn 0066-4804, 5 p.Article

Lack of Interaction Between the HIV Integrase Inhibitor S/GSK1349572 and Tenofovir in Healthy SubjectsSONG, Ivy; MIN, Sherene S; BORLAND, Julie et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 3, pp 365-367, issn 1525-4135, 3 p.Article

Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next-generation HIV integrase inhibitor, S/GSK1349572SONG, Ivy; BORLAND, Julie; SHUGUANG CHEN et al.British journal of clinical pharmacology. 2011, Vol 72, Num 1, pp 103-108, issn 0306-5251, 6 p.Article

Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravirSONG, Ivy; BORLAND, Julie; WAGNER, David et al.European journal of clinical pharmacology. 2014, Vol 70, Num 10, pp 1173-1179, issn 0031-6970, 7 p.Article

Antiviral activity, safety, and pharmacokinetics/ pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adultsMIN, Sherene; SLOAN, Louis; PISCITELLI, Stephen et al.AIDS (London). 2011, Vol 25, Num 14, pp 1737-1745, issn 0269-9370, 9 p.Article

Prevalent Polymorphisms in Wild-Type HIV-1 Integrase Are Unlikely To Engender Drug Resistance to Dolutegravir (S/GSK1349572)VAVRO, Cindy; HASAN, Samiul; NICHOLS, Garrett et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 3, pp 1379-1384, issn 0066-4804, 6 p.Article

Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin: Results of a Phase 1 Study Among Healthy SubjectsDOOLEY, Kelly E; SAYRE, Patrick; BORLAND, Julie et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 1, pp 21-27, issn 1525-4135, 7 p.Article

Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in HumansCASTELLINO, Stephen; MOSS, Lee; PISCITELLI, Stephen C et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 8, pp 3536-3546, issn 0066-4804, 11 p.Article